CRP is a key protein of the acute-phase response involved in inflammation and contributing to a pro-metastatic TME, while LRG1 can promote neovascularization under hypoxia by activating TGF-β signaling, thus supporting tumor growth. This evidence concerns the gene TGFB1 and neoplasm.